Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017
Olaniyi Ayobami, Niklas Willrich, Beneditta Suwono, et al.
Antimicrobial Resistance and Infection Control (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Carbapenem resistance in Acinetobacter baumannii , and their importance in hospital‐acquired infections: a scientific review
M. Hong Nguyen, Suresh G. Joshi
Journal of Applied Microbiology (2021) Vol. 131, Iss. 6, pp. 2715-2738
Open Access | Times Cited: 161
Acinetobacter baumannii in the critically ill: complex infections get complicated
Ilaria Cavallo, Alessandra Oliva, Rebecca Pages, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 55
Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic
Rafael Cantón, Desirèe Gijón, Patricia Ruíz-Garbajosa
Current Opinion in Critical Care (2020) Vol. 26, Iss. 5, pp. 433-441
Open Access | Times Cited: 107
Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019
Jason M. Pogue, Yun Zhou, Hemanth Kanakamedala, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Antimicrobial Resistance and the Spectrum of Pathogens in Dental and Oral-Maxillofacial Infections in Hospitals and Dental Practices in Germany
A. Meinen, Annicka Reuß, Niklas Willrich, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 46
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study
Alessandra Oliva, L Liguori, S. Covino, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2024) Vol. 43, Iss. 6, pp. 1149-1160
Open Access | Times Cited: 6
Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
Robby Markwart, Niklas Willrich, Tim Eckmanns, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 32
Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii
Meity Mardiana, Soon-Hian Teh, Ling‐Chun Lin, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1240-1240
Open Access | Times Cited: 24
Risk factors for transmission of carbapenem-resistant Acinetobacter baumannii in outbreak situations: results of a case-control study
B Schlosser, Beate Weikert, Giovanni-Battista Fucini, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Prediction Methods for Antimicrobial Resistance Trends in China
Zhengyang Wu, Ning Zhang, Bohan Zhang, et al.
Indian Journal of Microbiology (2025)
Closed Access
Blue benzoquinone from scorpion venom shows bactericidal activity against drug-resistant strains of the priority pathogen Acinetobacter baumannii
Ramsés Gallegos‐Monterrosa, Jimena I. Cid-Uribe, Gustavo Delgado-Prudencio, et al.
The Journal of Antibiotics (2025)
Open Access
Isolation and characterization a novel Acinetobacter bacteriophage with activity against several multidrug-resistant gram-negative bacteria
Yelda Işlek, Nur Hamzeli, Ahmet Aktaş, et al.
Microbial Pathogenesis (2025), pp. 107488-107488
Closed Access
The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system
Dunja Said, Niklas Willrich, Olaniyi Ayobami, et al.
Antimicrobial Resistance and Infection Control (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Bugs That Can Resist Antibiotics but Not Men: Gender-Specific Differences in Notified Infections and Colonisations in Germany, 2010–2019
Michael Brandl, Alexandra Hoffmann, Niklas Willrich, et al.
Microorganisms (2021) Vol. 9, Iss. 5, pp. 894-894
Open Access | Times Cited: 30
High-Resolution Bacterial Cytological Profiling Reveals Intrapopulation Morphological Variations upon Antibiotic Exposure
Thanadon Samernate, Htut Htut Htoo, Joseph Sugie, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 2
Open Access | Times Cited: 12
The Synergy of Machine Learning and Epidemiology in Addressing Carbapenem Resistance: A Comprehensive Review
Aikaterini Sakagianni, Christina Koufopoulou, Petros Koufopoulos, et al.
Antibiotics (2024) Vol. 13, Iss. 10, pp. 996-996
Open Access | Times Cited: 3
Evaluation of different methods for in vitro susceptibility testing of colistin in carbapenem resistant Gram-negative bacilli
Bidyutprava Rout, Sumesh Kumar Dash, Kundan Kumar Sahu, et al.
Access Microbiology (2023) Vol. 5, Iss. 10
Open Access | Times Cited: 8
Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case–control study
Yihai Gu, Yan Jiang, Wei Zhang, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 2, pp. 115229-115229
Open Access | Times Cited: 22
Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant Acinetobacter baumannii from Austria
Andrea Grisold, Josefa Luxner, Branka Bedenić, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 4, pp. 2171-2171
Open Access | Times Cited: 18
Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality model
Silvia Corcione, Bianca Maria Longo, Silvia Scabini, et al.
Journal of Global Antimicrobial Resistance (2024) Vol. 38, pp. 317-326
Open Access | Times Cited: 2
Coexistence of blaNDM-1, blaOXA-51, blaOXA-23, and armA in conjunction with novel mutations detected in RND efflux pump regulators in tigecycline resistant clinical isolates of Acinetobacter baumannii
Ajit Ramesh Sawant, Sudhakar Pagal, Ashutosh Kumar Amar, et al.
Pathogens and Disease (2022) Vol. 80, Iss. 1
Closed Access | Times Cited: 11
Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children
Yufei Zhang, Guifeng Xu, Fei Miao, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 6
Incidence, outcomes, and predictors of Acinetobacter infection in Saudi Arabian critical care units
Ayman Kharaba, Haifa Algethamy, Mohamed A. Hussein, et al.
Journal of Critical Care (2021) Vol. 66, pp. 109-116
Open Access | Times Cited: 13
Nosocomial transmission of tet(x3), blaNDM-1 and blaOXA-97-carrying Acinetobacter baumannii conferring resistance to eravacycline and omadacycline, the Netherlands, March to August 2021
D. Talsma, Rodrigo Monteiro, Rosario del Carmen Flores-Vallejo, et al.
Eurosurveillance (2024) Vol. 29, Iss. 28
Open Access | Times Cited: 1
Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015–2019)
Patrick Chhatwal, Ella Ebadi, Frank Schwab, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top